OSVALDO BATISTA: Open Payments
NPI 1245349224 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 53 payments from 10 companies in 2025. Trend: 2023 $476 · 2024 $867 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 28 | $397 |
| Abbott Laboratories | 5 | $112 |
| Lilly USA, LLC | 5 | $110 |
| SANOFI PASTEUR INC. | 4 | $90 |
| Novo Nordisk Inc | 5 | $85 |
| Amgen Inc. | 2 | $34 |
| ViiV Healthcare Company | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $25 |
| ABBVIE INC. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Wegovy, EVENITY, APRETUDE, Saxenda, BEXSERO.
Industry payments across CA — which companies pay providers there.
